Korsana Biosciences, Inc. Common Stock (CYCN)
Delisted
8 Sep 2026
NASDAQ (CM) NASDAQ (CM) Primary $
23. 52
0
0%
$
15.73M Market Cap
- P/E Ratio
- Div Yield
435,847 Volume
0 Eps
$ 23.52
Previous Close Investors:
Day Range
2.82 23.52
Year Range
2.82 59.36
Want to track CYCN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cyclerion Therapeutics, Inc. (CYCN) M&A Call Prepared Remarks Transcript
Cyclerion Therapeutics, Inc. (CYCN) M&A Call Prepared Remarks Transcript
Seekingalpha | 6 months ago
Cyclerion Therapeutics, Inc. (CYCN) Discusses Medsteer Development Collaboration and Updates on Phase 2 Proof-of-Concept Study in Treatment-Resistant Depression Prepared Remarks Transcript
Cyclerion Therapeutics, Inc. (CYCN) Discusses Medsteer Development Collaboration and Updates on Phase 2 Proof-of-Concept Study in Treatment-Resistant Depression Prepared Remarks Transcript
Seekingalpha | 9 months ago
2026 © Marketlog. All Rights Reserved.
